{"id":331365,"date":"2026-10-29T11:07:49","date_gmt":"2026-10-29T05:37:49","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=331365"},"modified":"2026-10-29T11:07:49","modified_gmt":"2026-10-29T05:37:49","slug":"paras-healthcare-share-price-today-up-about-13-percent-over-issue-price-after-listing-what-the-numbers-say-before-you-decide","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/paras-healthcare-share-price-today-up-about-13-percent-over-issue-price-after-listing-what-the-numbers-say-before-you-decide\/","title":{"rendered":"Paras Healthcare Share Price Today: Up 12.6% Over the Issue Price After Listing, What the Numbers Say Before You Decide"},"content":{"rendered":"

The Paras Healthcare share price was Rs 780.55 on the NSE, up 6.11%, at 10:59 AM IST on Thursday, 29 Oct 2026, which is 12.6% above the issue price of Rs 693 and 8.4% above the listing price of Rs 720 (my calculation), after the hospital operator listed on 28 Oct and closed its first day at Rs 735.60.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The Paras Healthcare share price was Rs 780.55, up 6.11%, at 10:59 AM IST on 29 Oct 2026, about 12.6% above the issue price of Rs 693 (my calculation). The shares listed on 28 Oct at Rs 720, a 3.9% premium, and closed the first day at Rs 735.60. The business grew revenue to Rs 1,628.78 crore in FY26 and turned a profit of Rs 43.83 crore after years of losses, but debt to equity is high at about 3.5 to 3.9 and the data provider’s price to earnings of 182 is far above the industry’s 60.65. This is educational and not a recommendation.<\/p>\n<\/p><\/div>\n

A stock that is up 12.6% over its issue price in two sessions prompts the usual question: buy, sell or hold? This article does not answer that for you. It explains what the Paras Healthcare share price is paying for, how the listing went, what the hospital business and its financials look like, how debt and the use of fresh money matter, how valuation measures differ and what the chart can and cannot tell you after only two sessions.<\/p>\n

Two flags. Valuation figures differ widely by source: the data provider shows a trailing price to earnings of 182.01, while brokers cited about 37.7 times on annualised June 2026 quarter earnings at the issue price. Also, the June 2026 quarter profit of Rs 49.68 crore is higher than the whole of FY26, and I could not confirm whether one-off items explain that. It is educational and not advice.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n